Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.

Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D.

Int J Mol Sci. 2017 Jul 3;18(7). pii: E1425. doi: 10.3390/ijms18071425. Review.

2.

Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.

Caprnda M, Kubatka P, Gazdikova K, Gasparova I, Valentova V, Stollarova N, La Rocca G, Kobyliak N, Dragasek J, Mozos I, Prosecky R, Siniscalco D, Büsselberg D, Rodrigo L, Kruzliak P.

Biomed Pharmacother. 2017 Jul;91:60-69. doi: 10.1016/j.biopha.2017.04.034. Epub 2017 May 23. Review.

PMID:
28448871
3.

Induced pluripotent stem cells as a cellular model for studying Down Syndrome.

Brigida AL, Siniscalco D.

J Stem Cells Regen Med. 2016 Nov 29;12(2):54-60. eCollection 2016. Review.

4.

Peripheral Inflammatory Markers Contributing to Comorbidities in Autism.

Inga Jácome MC, Morales Chacòn LM, Vera Cuesta H, Maragoto Rizo C, Whilby Santiesteban M, Ramos Hernandez L, Noris García E, González Fraguela ME, Fernandez Verdecia CI, Vegas Hurtado Y, Siniscalco D, Gonçalves CA, Robinson-Agramonte ML.

Behav Sci (Basel). 2016 Dec 14;6(4). pii: E29.

5.

Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.

Iovene MR, Bombace F, Maresca R, Sapone A, Iardino P, Picardi A, Marotta R, Schiraldi C, Siniscalco D, Serra N, de Magistris L, Bravaccio C.

Mycopathologia. 2017 Apr;182(3-4):349-363. doi: 10.1007/s11046-016-0068-6. Epub 2016 Sep 21.

PMID:
27655151
6.

Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder.

Siniscalco D, Mijatovic T, Bosmans E, Cirillo A, Kruzliak P, Lombardi VC, De Meirleir K, Antonucci N.

In Vivo. 2016 Mar-Apr;30(2):83-9.

PMID:
26912817
7.

Commentary: The Impact of Neuroimmune Alterations in Autism Spectrum Disorder.

Siniscalco D.

Front Psychiatry. 2015 Oct 8;6:145. doi: 10.3389/fpsyt.2015.00145. eCollection 2015. No abstract available.

8.

Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.

Antonucci N, Cirillo A, Siniscalco D.

Case Rep Psychiatry. 2015;2015:325061. doi: 10.1155/2015/325061. Epub 2015 Sep 29.

9.

Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.

Katuchova J, Harvanova D, Spakova T, Kalanin R, Farkas D, Durny P, Rosocha J, Radonak J, Petrovic D, Siniscalco D, Qi M, Novak M, Kruzliak P.

Endocr Pathol. 2015 May;26(2):95-103. doi: 10.1007/s12022-015-9362-y. Review.

PMID:
25762503
10.

Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.

Bradstreet JJ, Sych N, Antonucci N, Klunnik M, Ivankova O, Matyashchuk I, Demchuk M, Siniscalco D.

Cell Transplant. 2014;23 Suppl 1:S105-12. doi: 10.3727/096368914X684916. Epub 2014 Oct 9.

PMID:
25302490
11.

Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.

Rossi F, Perrotta S, Bellini G, Luongo L, Tortora C, Siniscalco D, Francese M, Torella M, Nobili B, Di Marzo V, Maione S.

Haematologica. 2014 Dec;99(12):1876-84. doi: 10.3324/haematol.2014.104463. Epub 2014 Sep 12.

12.
13.

Mesenchymal stem cells in treating autism: Novel insights.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

World J Stem Cells. 2014 Apr 26;6(2):173-8. doi: 10.4252/wjsc.v6.i2.173. Review.

14.

The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages.

Siniscalco D, Bradstreet JJ, Cirillo A, Antonucci N.

J Neuroinflammation. 2014 Apr 17;11:78. doi: 10.1186/1742-2094-11-78.

15.

Perspectives on the use of stem cells for autism treatment.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

Stem Cells Int. 2013;2013:262438. doi: 10.1155/2013/262438. Epub 2013 Oct 10. Review.

16.

Involvement of dietary bioactive proteins and peptides in autism spectrum disorders.

Siniscalco D, Antonucci N.

Curr Protein Pept Sci. 2013 Dec;14(8):674-9. Review.

17.

Epigenetic findings in autism: new perspectives for therapy.

Siniscalco D, Cirillo A, Bradstreet JJ, Antonucci N.

Int J Environ Res Public Health. 2013 Sep 11;10(9):4261-73. doi: 10.3390/ijerph10094261. Review.

18.

Antibodies against food antigens in patients with autistic spectrum disorders.

de Magistris L, Picardi A, Siniscalco D, Riccio MP, Sapone A, Cariello R, Abbadessa S, Medici N, Lammers KM, Schiraldi C, Iardino P, Marotta R, Tolone C, Fasano A, Pascotto A, Bravaccio C.

Biomed Res Int. 2013;2013:729349. doi: 10.1155/2013/729349. Epub 2013 Aug 1.

19.

Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation.

Siniscalco D, Bradstreet JJ, Antonucci N.

Front Immunol. 2013 Jun 10;4:140. doi: 10.3389/fimmu.2013.00140. eCollection 2013.

20.

Possible use of Trichuris suis ova in autism spectrum disorders therapy.

Siniscalco D, Antonucci N.

Med Hypotheses. 2013 Jul;81(1):1-4. doi: 10.1016/j.mehy.2013.03.024. Epub 2013 Apr 15. Review.

PMID:
23597946

Supplemental Content

Loading ...
Support Center